Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kristensen, GB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kristensen, GB; Sorensen, SR; Aamand, J
      Mineralization of 2,4-D, mecoprop, isoproturon and terbuthylazine in a chalk aquifer

      PEST MANAGEMENT SCIENCE
    2. Trope, C; Kristensen, GB; Abeler, VM
      Clear-cell and papillary serous cancer: treatment options

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    3. Davidson, B; Lazarovici, P; Ezersky, A; Nesland, JM; Berner, A; Risberg, B; Trope, CG; Kristensen, GB; Goscinski, M; van de Putte, G; Reich, R
      Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients

      CLINICAL CANCER RESEARCH
    4. Davidson, B; Reich, R; Berner, A; Givant-Horwitz, V; Goldberg, I; Risberg, B; Kristensen, GB; Trope, CG; Bryne, M; Kopolovic, J; Nesland, JM
      Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

      EUROPEAN JOURNAL OF CANCER
    5. Baekelandt, M; Lehne, G; Trope, CG; Szanto, I; Pfeiffer, P; Gustavssson, B; Kristensen, GB
      Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    6. Davidson, B; Risberg, B; Goldberg, I; Nesland, JM; Berner, A; Trope, CG; Kristensen, GB; Bryne, M; Reich, R
      Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients isa marker of poor outcome

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    7. Davidson, B; Risberg, B; Berner, A; Nesland, JM; Trope, CG; Kristensen, GB; Bryne, M; Goscinski, M; de Putte, GV; Florenes, VA
      Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications

      GYNECOLOGIC ONCOLOGY
    8. Kristensen, GB; Johannesen, H; Aamand, J
      Mineralization of aged atrazine and mecoprop in soil and aquifer chalk

      CHEMOSPHERE
    9. Alfsen, GC; Kristensen, GB; Skovlund, E; Pettersen, EO; Abeler, VM
      Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix - A population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix

      CANCER
    10. Davidson, B; Goldberg, I; Berner, A; Nesland, JM; Givant-Horwitz, V; Byrne, M; Risberg, B; Kristensen, GB; Trope, CG; Kopolovic, J; Reich, R
      Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions

      AJCP. American journal of clinical pathology
    11. Baekelandt, M; Holm, R; Nesland, JM; Trope, CG; Kristensen, GB
      Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    12. Berner, HS; Davidson, B; Berner, A; Risberg, B; Kristensen, GB; Trope, CG; Van de Putte, G; Nesland, JM
      Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications

      CLINICAL & EXPERIMENTAL METASTASIS
    13. Baekelandt, MM; Holm, R; Nesland, JM; Trope, CG; Kristensen, GB
      P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer

      ANTICANCER RESEARCH
    14. Paulsen, T; Marth, C; Kaern, J; Nustad, K; Kristensen, GB; Trope, C
      Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients

      GYNECOLOGIC ONCOLOGY
    15. Davidson, B; Berner, A; Nesland, JM; Risberg, B; Kristensen, GB; Trope, CG; Bryne, M
      Carbohydrate antigen expression in primary tumors, metastatic lesions, andserous effusions from patients diagnosed with epithelial ovarian carcinoma: Evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions

      HUMAN PATHOLOGY
    16. Davidson, B; Berner, A; Nesland, JM; Risberg, B; Berner, HS; Trope, CG; Kristensen, GB; Bryne, M; Florenes, VA
      E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions

      JOURNAL OF PATHOLOGY
    17. Helland, A; Kraggerud, SM; Kristensen, GB; Holm, R; Abeler, VM; Huebner, K; Borresen-Dale, AL; Lothe, RA
      Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RB1 and TP53 inrelation to survival

      INTERNATIONAL JOURNAL OF CANCER
    18. Alfsen, GC; Thoresen, SO; Kristensen, GB; Skovlund, E; Abeler, VM
      Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups - A population basedstudy with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990

      CANCER
    19. Baekelandt, M; Nesbakken, AJ; Kristensen, GB; Trope, CG; Abeler, VM
      Carcinoma of the fallopian tube - Clinicopathologic study of 151 patients treated at the Norwegian Radium Hospital

      CANCER
    20. Vergote, I; Rustin, GJS; Eisenhauer, EA; Kristensen, GB; Pujade-Lauraine, E; Parmar, MKB; Friedlander, M; Jakobsen, A; Vermorken, JB
      Re: New guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    21. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study

      CLINICAL CANCER RESEARCH
    22. Skomedal, H; Helland, A; Kristensen, GB; Holm, R; Borresen-Dale, AL
      Allelic imbalance at chromosome region 11q23 in cervical carcinomas

      EUROPEAN JOURNAL OF CANCER
    23. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer

      ANNALS OF ONCOLOGY
    24. Baekelandt, M; Kristensen, GB; Nesland, JM; Trope, CG; Holm, R
      Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 inadvanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    25. Baekelandt, M; Kristensen, GB; Trope, CG; Nesland, JM; Holm, R
      Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer

      ANTICANCER RESEARCH
    26. Teixeira, MR; Kristensen, GB; Abeler, VM; Heim, S
      Karyotypic findings in tumors of the vulva and vagina

      CANCER GENETICS AND CYTOGENETICS
    27. Kristensen, GB; Abeler, VM; Risberg, B; Trope, C; Bryne, M
      Tumor size, depth of invasion, and grading of the invasive tumor front arethe main prognostic factors in early squamous cell cervical carcinoma

      GYNECOLOGIC ONCOLOGY
    28. Skomedal, H; Kristensen, GB; Lie, AK; Holm, R
      Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21,p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas

      GYNECOLOGIC ONCOLOGY
    29. Skomedal, H; Kristensen, GB; Nesland, JM; Borresen-Dale, AL; Trope, C; Holm, R
      TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, cdk4, RB, MDM2, and EGFR in cancers of the uterine corpus

      JOURNAL OF PATHOLOGY
    30. Huinink, WWT; de Swart, CAM; van Toorn, DW; Morack, G; Breed, WPM; Hillen, HFP; van der Hoeven, JJM; Reed, NS; Fairlamb, DJ; Chan, SYT; Godfrey, KA; Kristensen, GB; van Tinteren, H; Ehmer, B
      Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients withovarian carcinoma treated with platinum-based chemotherapy

      MEDICAL ONCOLOGY
    31. MARTH C; TROPE C; VERGOTE IB; KRISTENSEN GB
      10-YEAR RESULTS OF A RANDOMIZED TRIAL COMPARING CISPLATIN WITH CISPLATIN AND CYCLOPHOSPHAMIDE IN ADVANCED, SUBOPTIMALLY DEBULKED OVARIAN-CANCER

      European journal of cancer
    32. SCHULERUD H; KRISTENSEN GB; LIESTOL K; VLATKOVIC L; REITH A; ALBREGTSEN F; DANIELSEN HE
      A REVIEW OF CAVEATS IN STATISTICAL NUCLEAR IMAGE-ANALYSIS

      Analytical cellular pathology
    33. HOFSTRA LS; KRISTENSEN GB; WILLEMSE PHB; VINDEVOGHEL A; MEDEN H; LAHOUSEN M; OBERLING F; SORBE B; CRUMP M; SKLENAR I; SLUITER WJ; KIESE B; TROPE CG; DEVRIES EGE
      RANDOMIZED TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-3 VERSUS PLACEBO INPREVENTION OF BONE-MARROW DEPRESSION DURING FIRST-LINE CHEMOTHERAPY FOR OVARIAN-CARCINOMA

      Journal of clinical oncology
    34. Bryne, M; Boysen, M; Alfsen, CG; Abeler, VM; Sudbo, J; Nesland, JM; Kristensen, GB; Piffko, J; Bankfalvi, A
      The invasive front of carcinomas. The most important area for tumour prognosis?

      ANTICANCER RESEARCH
    35. NORDAL RR; KRISTENSEN GB; STENWIG AE; TROPE CG; NESLAND JM
      IMMUNOHISTOCHEMICAL ANALYSIS OF P53 PROTEIN IN UTERINE SARCOMAS

      Gynecologic oncology (Print)
    36. KRISTENSEN GB; TROPE C
      EPITHELIAL OVARIAN-CARCINOMA

      Lancet
    37. NORDAL RR; KRISTENSEN GB; STENWIG AE; NESLAND JM; PETTERSEN EO; TROPE CG
      AN EVALUATION OF PROGNOSTIC FACTORS IN UTERINE CARCINOSARCOMA

      Gynecologic oncology
    38. SKOMEDAL H; KRISTENSEN GB; ABELER VM; BORRESENDALE AL; TROPE C; HOLM R
      TP53 PROTEIN ACCUMULATION AND GENE MUTATION IN RELATION TO OVEREXPRESSION OF MDM2 PROTEIN IN OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS

      Journal of pathology
    39. HELLAND A; BORRESENDALE AL; PELTOMAKI P; HEKTOEN M; KRISTENSEN GB; NESLAND JM; DELACHAPELLE A; LOTHE RA
      MICROSATELLITE INSTABILITY IN CERVICAL AND ENDOMETRIAL CARCINOMAS

      International journal of cancer
    40. KRISTENSEN GB; KARLSEN F; JENKINS A; KAERN J; ABELER VM; TROPE CG
      HUMAN PAPILLOMA-VIRUS HAS NO PROGNOSTIC-SIGNIFICANCE IN CERVICAL-CARCINOMA

      European journal of cancer
    41. DORUM A; KRISTENSEN GB; ABELER VM; TROPE CG; MOLLER P
      EARLY DETECTION OF FAMILIAL OVARIAN-CANCER

      European journal of cancer
    42. NORDAL RR; KRISTENSEN GB; KAERN J; STENWIG AE; PETTERSEN EO; TROPE CG
      THE PROGNOSTIC-SIGNIFICANCE OF SURGERY, TUMOR SIZE, MALIGNANCY GRADE,MENOPAUSAL STATUS, AND DNA-PLOIDY IN ENDOMETRIAL STROMAL SARCOMA

      Gynecologic oncology
    43. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF NM23 NDP KINASE PROTEIN EXPRESSION IN CERVICAL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY/

      Gynecologic oncology
    44. SCHEISTROEN M; TROPE C; KAERN J; ABELER VM; PETTERSEN EO; KRISTENSEN GB
      MALIGNANT-MELANOMA OF THE VULVA FIGO STAGE-I - EVALUATION OF PROGNOSTIC FACTORS IN 43 PATIENTS WITH EMPHASIS ON DNA-PLOIDY AND SURGICAL-TREATMENT

      Gynecologic oncology
    45. KAERN J; TROPE C; SUNDFOER K; KRISTENSEN GB
      CISPLATIN 5-FLUOROURACIL TREATMENT OF RECURRENT CERVICAL-CARCINOMA - A PHASE-II STUDY WITH LONG-TERM FOLLOW-UP/

      Gynecologic oncology
    46. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND C-ERBB-2 IN EARLY CERVICAL SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY

      Cancer
    47. HAGMAR B; CHRISTENSEN JJP; JOHANSSON B; KALANTARI M; RYD W; SKYLDBERG B; WALAAS L; WARLEBY B; KRISTENSEN GB
      IMPLICATIONS OF HUMAN PAPILLOMAVIRUS TYPE FOR SURVIVAL IN CERVICAL SQUAMOUS-CELL CARCINOMA

      International journal of gynecological cancer
    48. KRISTENSEN GB; BAEKELANDT M; VERGOTE IB; TROPE C
      A PHASE-II STUDY OF CARBOPLATIN AND HEXAMETHYLMELAMINE AS INDUCTION CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA

      European journal of cancer
    49. KRISTENSEN GB; BAEKELANDT M; VERGOTE IB; TROPE C
      A PHASE-II STUDY OF CARBOPLATIN AND HEXAMETHYLMELAMINE AS INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA (AOC)

      European journal of cancer
    50. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      THE PROGNOSTIC-SIGNIFICANCE OF NM23, CATHEPSIN-D, EGFR AND C-ERBB-2 IN CERVICAL-CANCER

      European journal of cancer
    51. NORDAL RR; KRISTENSEN GB; KAERN J; STENWIG AE; PETTERSEN EO; TROPE CG
      THE PROGNOSTIC-SIGNIFICANCE OF STAGE, TUMOR SIZE, CELLULAR ATYPIA ANDDNA-PLOIDY IN UTERINE LEIOMYOSARCOMA

      Acta oncologica
    52. KRISTENSEN GB; KAERN J; ABELER VM; HAGMAR B; TROPE CG; PETTERSEN EO
      NO PROGNOSTIC IMPACT OF FLOW-CYTOMETRIC MEASURED DNA-PLOIDY AND S-PHASE FRACTION IN CANCER OF THE UTERINE CERVIX - A PROSPECTIVE-STUDY OF 465 PATIENTS

      Gynecologic oncology
    53. MAKAR AP; BAEKELANDT M; TROPE CG; KRISTENSEN GB
      THE PROGNOSTIC-SIGNIFICANCE OF RESIDUAL DISEASE, FIGO SUBSTAGE, TUMORHISTOLOGY, AND GRADE IN PATIENTS WITH FIGO STAGE-III OVARIAN-CANCER

      Gynecologic oncology
    54. SCHEISTROEN M; TROPE C; KOERN J; PETTERSEN EO; ABELER VM; KRISTENSEN GB
      MALIGNANT-MELANOMA OF THE VULVA - EVALUATION OF PROGNOSTIC FACTORS WITH EMPHASIS ON DNA-PLOIDY IN 75 PATIENTS

      Cancer
    55. MAKAR AP; HOLM R; KRISTENSEN GB; NESLAND JM; TROPE CG
      THE EXPRESSION OF C-ERBB-2 (HER-2 NEU) ONCOGENE IN INVASIVE OVARIAN MALIGNANCIES/

      International journal of gynecological cancer
    56. DORUM A; KRISTENSEN GB; TROPE C
      RANDOMIZED STUDY OF CISPLATIN VERSUS THIOTEPA AS INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA

      European journal of cancer
    57. DORUM A; KRISTENSEN GB; TROPE C
      RANDOMIZED STUDY OF CISPLATIN VERSUS THIOTEPA AS INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA

      European journal of cancer
    58. KAERN J; TROPE CG; KRISTENSEN GB; PETTERSEN EO
      FLOW CYTOMETRIC DNA-PLOIDY AND S-PHASE HETEROGENEITY IN ADVANCED OVARIAN-CARCINOMA

      Cancer
    59. KAERN J; TROPE CG; KRISTENSEN GB; TVEIT KM; PETTERSEN EO
      EVALUATION OF DEOXYRIBONUCLEIC-ACID PLOIDY AND S-PHASE FRACTION AS PROGNOSTIC PARAMETERS IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A PROSPECTIVE-STUDY

      American journal of obstetrics and gynecology
    60. KAERN J; TROPE CG; KRISTENSEN GB; ABELER VM; PETTERSEN EO
      DNA-PLOIDY - THE MOST IMPORTANT PROGNOSTIC FACTOR IN PATIENTS WITH BORDERLINE TUMORS OF THE OVARY

      International journal of gynecological cancer
    61. MAKAR AP; KAERN J; KRISTENSEN GB; VERGOTE I; BORMER OP; TROPE CG
      EVALUATION OF SERUM CA-125 LEVEL AS A TUMOR-MARKER IN BORDERLINE TUMORS OF THE OVARY

      International journal of gynecological cancer
    62. MAKAR AP; KRISTENSEN GB; BORMER OP; TROPE CG
      IS SERUM CA-125 AT THE TIME OF RELAPSE A PROGNOSTIC INDICATOR FOR FURTHER SURVIVAL PROGNOSIS IN PATIENTS WITH OVARIAN-CANCER

      Gynecologic oncology
    63. MAKAR AP; KRISTENSEN GB; BORMER OP; TROPE CG
      SERUM CA-125 LEVEL ALLOWS EARLY IDENTIFICATION OF NONRESPONDERS DURING INDUCTION CHEMOTHERAPY

      Gynecologic oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 14:06:41